First National Trust’s Boston Scientific BSX Stock Holding History

First National Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Sell	47,888 -64,589	-57%	-$3.51M	0.07%	167
2026 Q1	$7.06M	Sell	112,477 -3,693	-3%	-$295K	0.24%	95
2025 Q4	$11.1M	Buy	116,170 +1,364	+1%	+$134K	0.37%	60
2025 Q3	$11.2M	Buy	114,806 +2,504	+2%	+$259K	0.38%	62
2025 Q2	$12.1M	Sell	112,302 -2,704	-2%	-$274K	0.45%	55
2025 Q1	$11.6M	Sell	115,006 -5,604	-5%	-$564K	0.47%	55
2024 Q4	$10.8M	Sell	120,610 -2,311	-2%	-$203K	0.4%	61
2024 Q3	$10.3M	Sell	122,921 -289	-0.2%	-$22.8K	0.4%	60
2024 Q2	$9.49M	Sell	123,210 -9,827	-7%	-$719K	0.39%	59
2024 Q1	$9.11M	Sell	133,037 -100,262	-43%	-$6.45M	0.37%	67
2023 Q4	$13.5M	Sell	233,299 -29,779	-11%	-$1.59M	0.59%	47
2023 Q3	$13.9M	Buy	263,078 +7,645	+3%	+$401K	0.66%	43
2023 Q2	$13.8M	Buy	255,433 +5,091	+2%	+$266K	0.64%	44
2023 Q1	$12.5M	Sell	250,342 -356	-0.1%	-$16.8K	0.67%	45
2022 Q4	$11.6M	Buy	250,698 +5,304	+2%	+$230K	0.61%	51
2022 Q3	$9.51M	Buy	245,394 +11,474	+5%	+$460K	0.55%	57
2022 Q2	$8.72M	Buy	233,920 +17,639	+8%	+$718K	0.49%	62
2022 Q1	$9.58M	Buy	216,281 +33,081	+18%	+$1.43M	0.5%	66
2021 Q4	$7.78M	Buy	+183,200	New	+$7.7M	0.41%	80

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First National Trust's BSX Position: Q2 2026 in Review

First National Trust reduced its Boston Scientific (BSX) stake by 57% in Q2 2026, selling an estimated $3.51M and leaving 47,888 shares worth $2.04M. The position accounts for 0.07% of the portfolio, ranked #167.

First National Trust first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.9M in Q3 2023. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

First National Trust held 47,888 shares of Boston Scientific worth $2.04M as of Q2 2026.
First National Trust sold 64,589 Boston Scientific shares in Q2 2026, an estimated $3.51M.
Boston Scientific made up 0.07% of First National Trust's portfolio in Q2 2026, its #167 holding.
First National Trust first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
First National Trust's Boston Scientific position peaked at $13.9M in Q3 2023.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on First National Trust's 13F filing for Q2 2026, filed 30 Jul 2026.